Stuart J. Mickel

3.3k total citations · 1 hit paper
33 papers, 2.1k citations indexed

About

Stuart J. Mickel is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Stuart J. Mickel has authored 33 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 13 papers in Organic Chemistry and 12 papers in Oncology. Recurrent topics in Stuart J. Mickel's work include Neuroscience and Neuropharmacology Research (10 papers), Cancer Treatment and Pharmacology (9 papers) and Synthetic Organic Chemistry Methods (6 papers). Stuart J. Mickel is often cited by papers focused on Neuroscience and Neuropharmacology Research (10 papers), Cancer Treatment and Pharmacology (9 papers) and Synthetic Organic Chemistry Methods (6 papers). Stuart J. Mickel collaborates with scholars based in Switzerland, United States and United Kingdom. Stuart J. Mickel's co-authors include Wolfgang Froestl, H. Bittiger, R H Rownd, Klemens Kaupmann, Jakob Heid, Bernhard Bettler, Serge Bischoff, Christof Angst, Peter J. Flor and Gary McMaster and has published in prestigious journals such as Nature, Journal of Bacteriology and Annals of the New York Academy of Sciences.

In The Last Decade

Stuart J. Mickel

31 papers receiving 1.9k citations

Hit Papers

Expression cloning of GABAB receptors uncovers similarity... 1997 2026 2006 2016 1997 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stuart J. Mickel Switzerland 16 1.2k 1.1k 337 206 148 33 2.1k
James F. Koerner United States 27 1.7k 1.5× 935 0.9× 227 0.7× 361 1.8× 178 1.2× 59 2.5k
Wha Bin Im United States 28 1.4k 1.2× 771 0.7× 435 1.3× 112 0.5× 68 0.5× 85 2.3k
Ram K. Mishra Canada 34 2.0k 1.7× 1.9k 1.8× 452 1.3× 111 0.5× 228 1.5× 162 3.6k
Creed W. Abell United States 24 919 0.8× 722 0.7× 236 0.7× 113 0.5× 55 0.4× 79 2.2k
Nancy C. Lan United States 28 972 0.8× 1.1k 1.0× 157 0.5× 617 3.0× 135 0.9× 41 2.9k
Mark J. Wall United Kingdom 30 1.5k 1.2× 1.2k 1.1× 228 0.7× 160 0.8× 409 2.8× 97 3.0k
Milt Teitler United States 32 1.6k 1.3× 1.6k 1.4× 550 1.6× 57 0.3× 116 0.8× 73 2.8k
Eric Vieira Switzerland 18 825 0.7× 542 0.5× 430 1.3× 91 0.4× 99 0.7× 25 1.4k
Masaaki Tsuda Japan 30 1.4k 1.2× 931 0.9× 92 0.3× 431 2.1× 180 1.2× 98 2.5k
Olivier Nosjean France 23 1.1k 0.9× 384 0.4× 246 0.7× 76 0.4× 127 0.9× 52 2.0k

Countries citing papers authored by Stuart J. Mickel

Since Specialization
Citations

This map shows the geographic impact of Stuart J. Mickel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stuart J. Mickel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stuart J. Mickel more than expected).

Fields of papers citing papers by Stuart J. Mickel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stuart J. Mickel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stuart J. Mickel. The network helps show where Stuart J. Mickel may publish in the future.

Co-authorship network of co-authors of Stuart J. Mickel

This figure shows the co-authorship network connecting the top 25 collaborators of Stuart J. Mickel. A scholar is included among the top collaborators of Stuart J. Mickel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stuart J. Mickel. Stuart J. Mickel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mickel, Stuart J.. (2005). Toward a Commercial Synthesis of (+)‐Discodermolide. ChemInform. 36(20). 3 indexed citations
2.
Gunasekera, Sarath P., Stuart J. Mickel, Robert Daeffler, et al.. (2004). Synthetic Analogues of the Microtubule-Stabilizing Agent (+)-Discodermolide:  Preparation and Biological Activity. Journal of Natural Products. 67(5). 749–756. 13 indexed citations
5.
Froestl, Wolfgang, Bernhard Bettler, H. Bittiger, et al.. (2003). Ligands for expression cloning and isolation of GABAB receptors. Il Farmaco. 58(3). 173–183. 14 indexed citations
6.
Froestl, Wolfgang, Bernhard Bettler, H. Bittiger, et al.. (2001). Ligands for expression cloning and isolation of GABAB receptors. Il Farmaco. 56(1-2). 101–105. 1 indexed citations
7.
Kaupmann, Klemens, Jakob Heid, Peter J. Flor, et al.. (1997). Expression cloning of GABAB receptors uncovers similarity to metabotropic glutamate receptors. Nature. 386(6622). 239–246. 831 indexed citations breakdown →
8.
9.
Froestl, Wolfgang, Stuart J. Mickel, G. VON SPRECHER, et al.. (1995). Phosphinic Acid Analogs of GABA. 2. Selective, Orally Active GABAB Antagonists. Journal of Medicinal Chemistry. 38(17). 3313–3331. 168 indexed citations
10.
Froestl, Wolfgang, Stuart J. Mickel, Roger G. Hall, et al.. (1995). Phosphinic Acid Analogs of GABA. 1. New Potent and Selective GABAB Agonists. Journal of Medicinal Chemistry. 38(17). 3297–3312. 171 indexed citations
11.
Froestl, Wolfgang, Stuart J. Mickel, Roger G. Hall, et al.. (1995). ChemInform Abstract: Phosphinic Acid Analogues of GABA. Part 1. New Potent and Selective GABAB Agonists.. ChemInform. 26(51). 15 indexed citations
12.
Waldmeier, P. C., Peter Wicki, J.-J. Feldtrauer, et al.. (1994). GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. British Journal of Pharmacology. 113(4). 1515–1521. 82 indexed citations
13.
Olpe, Hans-Rudolf, Martin W. Steinmann, Mario F. Pozza, et al.. (1993). The actions of orally active GABAB receptor antagonists on GABAergic transmission in vivo and in vitro. European Journal of Pharmacology. 233(2-3). 179–186. 79 indexed citations
14.
Bittiger, H., Wolfgang Froestl, Stuart J. Mickel, & Hans-Rudolf Olpe. (1993). GABAB receptor antagonists: from synthesis to therapeutic applications. Trends in Pharmacological Sciences. 14(11). 391–394. 83 indexed citations
15.
Brugger, Felix, et al.. (1993). The action of new potent GABAB receptor antagonists in the hemisected spinal cord preparation of the rat. European Journal of Pharmacology. 235(1). 153–155. 40 indexed citations
16.
Mickel, Stuart J., et al.. (1993). Overview: Potent GABABAgonists and Antagonists. 3(5). 561–567. 2 indexed citations
17.
Campbell, Malcolm M., et al.. (1991). (±)-2-amino-2-thiazoline-4-ethanoic acid; a novel, specific GABAA receptor agonist. Bioorganic & Medicinal Chemistry Letters. 1(5). 247–248. 3 indexed citations
18.
Hershberger, Charles L., Stuart J. Mickel, & R H Rownd. (1971). Asymmetric Distribution of Guanine Plus Thymine Between Complementary Strands of Deoxyribonucleic Acid of Members of the Enterobacteriaceae. Journal of Bacteriology. 106(1). 238–242. 16 indexed citations
19.
Rownd, R H, Harumi Kasamatsu, & Stuart J. Mickel. (1971). THE MOLECULAR NATURE AND REPLICATION OF DRUG RESISTANCE FACTORS OF THE ENTEROBACTERIACEAE*. Annals of the New York Academy of Sciences. 182(1). 188–206. 47 indexed citations
20.
Rownd, R H & Stuart J. Mickel. (1971). Dissociation and Reassociation of RTF and r-Determinants of the R-factor NR1 in Proteus mirabilis. Nature New Biology. 234(45). 40–43. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026